Guaiacol as a drug candidate for treating adult polyglucosan body disease-Reference-Cited by-同舟云学术

Guaiacol as a drug candidate for treating adult polyglucosan body disease

Published:2018-09-06 Issue:17 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Kakhlon Or,Ferreira Igor,Solmesky Leonardo J.,Khazanov Netaly,Lossos Alexander,Alvarez Rafael,Yetil Deniz,Pampou Sergey,Weil Miguel,Senderowitz Hanoch,Escriba Pablo,Yue Wyatt W.,Akman H. Orhan

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/99694/files/pdf

Reference29 articles.

1. Post-modern therapeutic approaches for progressive myoclonus epilepsy;Minassian;Epileptic Disord,2016

2. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy

3. Abnormal Metabolism of Glycogen Phosphate as a Cause for Lafora Disease

4. A DISTINCT FORM OF ADULT POLYGLUCOSAN BODY DISEASE WITH MASSIVE INVOLVEMENT OF CENTRAL AND PERIPHERAL NEURONAL PROCESSES AND ASTROCYTES

5. Polyglucosan storage myopathies

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurological glycogen storage diseases and emerging therapeutics;Neurotherapeutics;2024-09

2. Natural history study of hepatic glycogen storage disease type IV and comparison to Gbe1ys/ys model;JCI Insight;2024-05-14

3. Non-oncogene dependencies: Novel opportunities for cancer therapy;Biochemical Pharmacology;2024-05

4. A Strategy to Obtain Lignin-Based Alkyl-Free Phenols under Mild Conditions: Condensation Inhibition and C_ar–C_α Bond Cleavage;ACS Sustainable Chemistry & Engineering;2024-03-11

5. A United States-based patient-reported adult polyglucosan body disease registry: initial results;Therapeutic Advances in Rare Disease;2024-01